Abiopharma

🔍 Neos Partners, LP (Executive)

Company: Forgent Power Solutions, Inc. (FPS)

Report Date: 2026-03-30

Detailed Transactions and Holdings:

• Acquired 10,783,205 shares of Class A common stock (Direct)
  Date: 2026-03-30 | Code: A | equity_swap_involved: false | shares_owned_after: 179,718,850.00 | transaction_form_type: 4 | Footnotes: F2, F3, F2, F4, F1
• Sold 34,500,000 shares of Class A common stock (Direct)
  Date: 2026-03-30 | Code: S | equity_swap_involved: false | shares_owned_after: 145,218,850.00 | transaction_form_type: 4 | Footnotes: F5, F6, F7, F1
• Holds 0 shares of Class A common stock (Direct)
  Date: 2026-03-30 | Code: H | shares_owned_after: 46,756.00 | Footnotes: F8
• Sold 10,783,205 shares of Opco LLC Interests (Derivative)
  Date: 2026-03-30 | Code: D | equity_swap_involved: false | shares_owned_after: 60,310,039.00 | transaction_form_type: 4 | Footnotes: F2, F3, F2, F2, F2, F2, F3, F9, F1

Footnotes:

• F1: See Exhibit 99.1 for text of footnote (1).
• F2: See Exhibit 99.1 for text of footnote (2).
• F3: See Exhibit 99.1 for text of footnote (3).
• F4: See Exhibit 99.1 for text of footnote (4).
• F5: See Exhibit 99.1 for text of footnote (5).
• F6: See Exhibit 99.1 for text of footnote (6.)
• F7: See Exhibit 99.1 for text of footnote (7).
• F8: See Exhibit 99.1 for text of footnote (8).
• F9: See Exhibit 99.1 for text of footnote (9).
• F10: See Exhibit 99.1 for text of footnote (10).
• F11: See Exhibit 99.1 for text of footnote (11).
• REMARKS: Exhibit 99.1 (Footnotes) and Exhibit 99.2 (Joint Filer Information and Signatures) are incorporated herein by reference. This Form 4 is the third of three identical Form 4s filed relating to the same event. The Form 4 has been split into three filings because there are more than 10 Reporting Persons in total, and the SEC's EDGAR filing system limits a single Form 4 to a maximum of 10 Reporting Persons. Each Form 4 is filed by Designated Filer, Neos Partners, LP.